Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sotiris Vandoros, Ph.D.

Title
Institution
Department
Address

Biography
education and training
London School of EconomicsPhD

Overview
overview
Dr Sotiris Vandoros is Associate Professor of Health Economics and Associate Dean at King’s College London, and Adjunct Associate Professor at Harvard School of Public Health.

He holds a PhD from the London School of Economics, where he has also previously worked as a Postdoctoral Researcher and a Research Fellow.

His fields of interest include health economics and behavioral science. In particular, his research focuses on the impact of economic conditions, shocks and uncertainty on health and health-related behaviours, and on regulation and competition in pharmaceutical markets, studying topics such as the generics paradox and therapeutic substitution.

Sotiris has carried out research for national and international organisations and governments such as the WHO, the NHS, the European Commission and the European Parliament. He has taught on postgraduate programmes at Harvard, King’s College London, LSE, Sorbonne-Cité and the Tata Institute of Social Sciences.
webpage

Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kyriopoulos I, Vandoros S, Kawachi I. Police killings and suicide among Black Americans. Soc Sci Med. 2022 07; 305:114964. PMID: 35660700.
    Citations:    Fields:    Translation:Humans
  2. Vandoros S, Kawachi I. Minimum Alcohol Pricing and Motor Vehicle Collisions in Scotland. Am J Epidemiol. 2022 03 24; 191(5):867-873. PMID: 34849531.
    Citations:    Fields:    Translation:Humans
  3. Velias A, Georganas S, Vandoros S. COVID-19: Early evening curfews and mobility. Soc Sci Med. 2022 01; 292:114538. PMID: 34823131; PMCID: PMC8588835.
    Citations:    Fields:    Translation:HumansCellsPHPublic Health
  4. Vandoros S, Kawachi I. Economic uncertainty and suicide in the United States. Eur J Epidemiol. 2021 Jun; 36(6):641-647. PMID: 34114185.
    Citations:    Fields:    Translation:Humans
  5. Vandoros S. COVID-19, lockdowns and motor vehicle collisions: empirical evidence from Greece. Inj Prev. 2022 02; 28(1):81-85. PMID: 33963056.
    Citations: 4     Fields:    Translation:HumansCellsPHPublic Health
  6. Kavetsos, G., Kawachi, I., Kyriopoulos, I. and Vandoros, S. The effect of the Brexit referendum result on subjective well-being. Journal of the Royal Statistical Society: Series A (Statistics in Society). 2021; 184(2):707-731. View Publication.
  7. Vandoros S, Gong X, Kawachi I. The link between unemployment and opioid prescribing. An instrumental variable approach using evidence from England. J Epidemiol Community Health. 2020 Oct 22. PMID: 33093186.
    Citations: 1     Fields:    
  8. Vandoros S. Invited Commentary: The Association Between Florida's Opioid Crackdown and Opioid-Related Mortality-The Roles of Economic Factors and Mortality Misclassification. Am J Epidemiol. 2020 09 01; 189(9):894-897. PMID: 32077473.
    Citations: 3     Fields:    Translation:Humans
  9. Vandoros S. Excess mortality during the Covid-19 pandemic: Early evidence from England and Wales. Soc Sci Med. 2020 08; 258:113101. PMID: 32521411.
    Citations: 39     Fields:    Translation:HumansPHPublic Health
  10. Dioikitopoulos EV, Minos D, Vandoros S. The (Agri-)Cultural origins of obesity. Soc Sci Med. 2020 01; 244:112523. PMID: 31689564.
    Citations:    Fields:    Translation:Humans
  11. Vandoros S, Kawachi I. The relative risk of motor vehicle collision on cannabis celebration day in Great Britain. Accid Anal Prev. 2019 Jul; 128:248-252. PMID: 30902341.
    Citations: 1     Fields:    Translation:HumansAnimals
  12. Vandoros S, Avendano M, Kawachi I. The association between economic uncertainty and suicide in the short-run. Soc Sci Med. 2019 01; 220:403-410. PMID: 30529798.
    Citations: 14     Fields:    Translation:Humans
  13. Vandoros S, Avendano M, Kawachi I. The EU referendum and mental health in the short term: a natural experiment using antidepressant prescriptions in England. J Epidemiol Community Health. 2019 02; 73(2):168-175. PMID: 30464033.
    Citations: 5     Fields:    Translation:Humans
  14. Vandoros S, Avendano M, Kawachi I. The short-term impact of economic uncertainty on motor vehicle collisions. Prev Med. 2018 06; 111:87-93. PMID: 29427672.
    Citations: 1     Fields:    Translation:Humans
  15. Jofre-Bonet M, Serra-Sastre V, Vandoros S. The impact of the Great Recession on health-related risk factors, behaviour and outcomes in England. Soc Sci Med. 2018 01; 197:213-225. PMID: 29257987.
    Citations: 13     Fields:    Translation:Humans
  16. Petrou P, Vandoros S. Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it? Health Policy. 2018 02; 122(2):75-80. PMID: 29274916.
    Citations: 3     Fields:    Translation:Humans
  17. van der Windt P, Vandoros S. Democracy and health: Evidence from within-country heterogeneity in the Congo. Soc Sci Med. 2017 12; 194:10-16. PMID: 29055183.
    Citations: 2     Fields:    Translation:Humans
  18. de Bruijn W, Ibáñez C, Frisk P, Bak Pedersen H, Alkan A, Vella Bonanno P, Brkicic LS, Bucsics A, Dedet G, Eriksen J, Fadare JO, Fürst J, Gallego G, Godói IP, Guerra Júnior AA, Gürsöz H, Jan S, Jones J, Joppi R, Kerman S, Laius O, Madzikwa N, Magnússon E, Maticic M, Markovic-Pekovic V, Massele A, Ogunleye O, O'Leary A, Piessnegger J, Sermet C, Simoens S, Tiroyakgosi C, Truter I, Thyberg M, Tomekova K, Wladysiuk M, Vandoros S, Vural EH, Zara C, Godman B. Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future. Front Pharmacol. 2016; 7:197. PMID: 27516740; PMCID: PMC4964878.
    Citations: 14     
  19. Vandoros S, Kavetsos G. Now or later? Understanding the etiologic period of suicide. Prev Med Rep. 2015; 2:809-11. PMID: 26844154; PMCID: PMC4721289.
    Citations:    
  20. Petrou P, Vandoros S. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment. Health Policy. 2015 May; 119(5):563-8. PMID: 25837234.
    Citations: 5     Fields:    
  21. Hessel P, Vandoros S, Avendano M. The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach. Public Health. 2014 Oct; 128(10):911-9. PMID: 25369355; PMCID: PMC4393742.
    Citations: 15     Fields:    Translation:Humans
  22. Guy Liu, Ali Mirzaei, Sotiris Vandoros. The impact of bank competition and concentration on industrial growth. Economics Letters. 2014; 124(1):60-63. View Publication.
  23. Rudisill C, Vandoros S, Antoun JG. Pharmaceutical policy reform in the Russian Federation. J Health Polit Policy Law. 2014 Jun; 39(3):691-705. PMID: 24603082.
    Citations: 5     Fields:    Translation:Humans
  24. Vandoros S, Kanavos P . Parallel Trade and Pharmaceutical Prices: A Game-theoretic Approach and Empirical Evidence from the E uropean Union. The World Economy. 2014; 6(37):856-880. View Publication.
  25. Hessel P, Vandoros S, Avendano M. The differential impact of the financial crisis on health in Ireland and Greece: a quasi-experimental approach. Public Health. 2014; 10(128):911-919. View Publication.
  26. Sotiris Vandoros. My five pounds are not as good as yours, so I will spend them. Experimental Economics. 2013; 16(4):546–559. View Publication.
  27. Vandoros S, Kavetsos G, Dolan P. Greasy roads: the impact of bad financial news on road traffic accidents. Risk Anal. 2014 Mar; 34(3):556-66. PMID: 24117892.
    Citations: 3     Fields:    Translation:Humans
  28. Vandoros S, Stargardt T. Authors' response to "Health service expenditures and efficiencies in Greece" (I). Health Policy. 2013 Jul; 111(2):208-9. PMID: 23706524.
    Citations:    Fields:    Translation:Humans
  29. Vandoros S. Therapeutic substitution post-patent expiry: the cases of ACE inhibitors and proton pump inhibitors. Health Econ. 2014 May; 23(5):621-30. PMID: 23696193.
    Citations: 2     Fields:    Translation:Humans
  30. Kanavos P, Ferrario A, Vandoros S, Anderson GF. Higher US branded drug prices and spending compared to other countries may stem partly from quick uptake of new drugs. Health Aff (Millwood). 2013 Apr; 32(4):753-61. PMID: 23569056.
    Citations: 24     Fields:    Translation:Humans
  31. Vandoros S, Hessel P, Leone T, Avendano M. Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach. Eur J Public Health. 2013 Oct; 23(5):727-31. PMID: 23417622.
    Citations: 41     Fields:    Translation:Humans
  32. Vandoros S, Kanavos P. The generics paradox revisited: empirical evidence from regulated markets. Applied Economics. 2013; 22(45):3230-3239.
  33. Vandoros S, Stargardt T. Reforms in the Greek pharmaceutical market during the financial crisis. Health Policy. 2013 Jan; 109(1):1-6. PMID: 22959163.
    Citations: 14     Fields:    
  34. Naci H, Cylus J, Vandoros S, Sato A, Perampaladas K. Raising the bar for market authorisation of new drugs. BMJ. 2012 Aug 07; 345:e4261. PMID: 22872693.
    Citations: 9     Fields:    
  35. Bradley J, Vandoros S. Creative compliance in pharmaceutical markets: the case of profit controls. Expert Rev Pharmacoecon Outcomes Res. 2012 Feb; 12(1):31-8. PMID: 22280194.
    Citations: 1     Fields:    Translation:Humans
  36. von der Schulenburg F, Vandoros S, Kanavos P. The effects of drug market regulation on pharmaceutical prices in Europe: overview and evidence from the market of ACE inhibitors. Health Econ Rev. 2011 Nov 21; 1(1):18. PMID: 22828053.
    Citations: 6     
  37. Kanavos PG, Vandoros S. Determinants of branded prescription medicine prices in OECD countries. Health Econ Policy Law. 2011 Jul; 6(3):337-67. PMID: 21676345.
    Citations: 12     Fields:    Translation:Humans
  38. Bertoldi AD, Barros AJ, Camargo AL, Hallal PC, Vandoros S, Wagner A, Ross-Degnan D. Household expenditures for medicines and the role of free medicines in the Brazilian public health system. Am J Public Health. 2011 May; 101(5):916-21. PMID: 20724692; PMCID: PMC3076418.
    Citations: 4     Fields:    Translation:Humans
  39. Kanavos P, Vandoros S . Competition in prescription drug markets: is parallel trade the answer?. Managerial & Decision Economics. 2010; 5(31):325-338. View Publication.
  40. Kanavos P, Vandoros S, Garcia-Gonzalez P. Benefits of global partnerships to facilitate access to medicines in developing countries: a multi-country analysis of patients and patient outcomes in GIPAP. Global Health. 2009 Dec 31; 5:19. PMID: 20043820.
    Citations: 12     Fields:    
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: SPH faculty should contact Faculty Affairs at facultyaffairshsph.harvard.edu).
Vandoros's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (131)
Explore
_
Co-Authors (3)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2023 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.